• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性核上性麻痹和皮质基底节变性中的关键新出现问题。

Key emerging issues in progressive supranuclear palsy and corticobasal degeneration.

作者信息

Josephs Keith A

机构信息

Behavioural Neurology and Movement Disorders, Mayo Clinic, Rochester, MN, 55905, USA,

出版信息

J Neurol. 2015 Mar;262(3):783-8. doi: 10.1007/s00415-015-7682-y. Epub 2015 Feb 21.

DOI:10.1007/s00415-015-7682-y
PMID:25701010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4372246/
Abstract

It has been approximately 50 years since neurologists were introduced to the entities, "progressive supranuclear palsy" and "corticobasal degeneration". Since the two seminal publications, there have been significant advancements in our understanding of these two neurodegenerative diseases, particularly the fact that both are associated with tau. Recent advances over the past 3 years that are notable to the field are discussed in this review that covers clinical diagnosis, pathological features, neuroimaging and CSF biomarkers, genetic associations and clinical trials related to progressive supranuclear palsy and corticobasal degeneration.

摘要

自神经科医生首次接触到“进行性核上性麻痹”和“皮质基底节变性”这两种病症以来,已经过去了大约50年。自这两篇具有开创性的论文发表以来,我们对这两种神经退行性疾病的认识有了重大进展,尤其是认识到这两种疾病都与tau蛋白有关。本综述讨论了过去3年该领域值得关注的最新进展,内容涵盖进行性核上性麻痹和皮质基底节变性的临床诊断、病理特征、神经影像学、脑脊液生物标志物、基因关联以及临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c2e/4372246/9758715977d3/nihms666388f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c2e/4372246/816c416cfd98/nihms666388f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c2e/4372246/9758715977d3/nihms666388f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c2e/4372246/816c416cfd98/nihms666388f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c2e/4372246/9758715977d3/nihms666388f2.jpg

相似文献

1
Key emerging issues in progressive supranuclear palsy and corticobasal degeneration.进行性核上性麻痹和皮质基底节变性中的关键新出现问题。
J Neurol. 2015 Mar;262(3):783-8. doi: 10.1007/s00415-015-7682-y. Epub 2015 Feb 21.
2
Analysis of PITX3 gene in patients with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration.多系统萎缩、进行性核上性麻痹和皮质基底节变性患者的PITX3基因分析。
Ann Clin Lab Sci. 2013 Spring;43(2):151-3.
3
Does corticobasal degeneration exist? A clinicopathological re-evaluation.皮质基底节变性是否存在?临床病理再评估。
Brain. 2010 Jul;133(Pt 7):2045-57. doi: 10.1093/brain/awq123.
4
Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.额颞叶痴呆与皮质基底节变性/进行性核上性麻痹之间的关系。
Dement Geriatr Cogn Disord. 2004;17(4):282-6. doi: 10.1159/000077155.
5
Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.4 型tau 病的结构和功能成像生物标志物的神经病理学相关性。
Brain. 2019 Jul 1;142(7):2068-2081. doi: 10.1093/brain/awz122.
6
Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.进行性核上性麻痹和皮质基底节变性:合并与区分
Mov Disord. 2005 Aug;20 Suppl 12:S21-8. doi: 10.1002/mds.20536.
7
Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration.进行性核上性麻痹和皮质基底节变性中的病理异质性。
Neuropathology. 2004 Mar;24(1):79-86. doi: 10.1111/j.1440-1789.2003.00543.x.
8
Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy.在皮质基底节变性和进行性核上性麻痹中,聚集tau蛋白的细胞内加工过程存在差异。
Neuroreport. 2001 Apr 17;12(5):935-8. doi: 10.1097/00001756-200104170-00014.
9
Corticobasal degeneration: key emerging issues.皮质基底节变性:关键的新兴问题。
J Neurol. 2018 Feb;265(2):439-445. doi: 10.1007/s00415-017-8644-3. Epub 2017 Oct 23.
10
Dual pathology of corticobasal degeneration and Parkinson's disease in a patient with clinical features of progressive supranuclear palsy.皮质基底节变性和帕金森病的双重病理学在以进行性核上性麻痹为临床特征的患者中。
Neurol India. 2011 Nov-Dec;59(6):887-90. doi: 10.4103/0028-3886.91371.

引用本文的文献

1
An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.进行性核上性麻痹言语/语言变异型的评估
Mov Disord Clin Pract. 2019 May 29;6(6):452-461. doi: 10.1002/mdc3.12796. eCollection 2019 Jul.
2
Tau tubulin kinases in proteinopathy.tau 微管相关蛋白激酶在蛋白病中的作用。
FEBS J. 2019 Jul;286(13):2434-2446. doi: 10.1111/febs.14866. Epub 2019 May 22.
3
Brain gray matter abnormalities in progressive supranuclear palsy revisited.重新审视进行性核上性麻痹中的脑灰质异常。

本文引用的文献

1
Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study.帕金森病、多系统萎缩和进行性核上性麻痹的扩散张量成像:基于纤维束的空间统计学研究
PLoS One. 2014 Nov 18;9(11):e112638. doi: 10.1371/journal.pone.0112638. eCollection 2014.
2
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.进行性核上性麻痹的表型谱:100例确诊病例的回顾性多中心研究
Mov Disord. 2014 Dec;29(14):1758-66. doi: 10.1002/mds.26054. Epub 2014 Nov 5.
3
A disease-specific metabolic brain network associated with corticobasal degeneration.
Oncotarget. 2017 Sep 15;8(46):80941-80955. doi: 10.18632/oncotarget.20895. eCollection 2017 Oct 6.
4
Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.脆性X相关震颤/共济失调综合征:与其他运动障碍的表型比较。
Clin Neuropsychol. 2016 Aug;30(6):849-900. doi: 10.1080/13854046.2016.1202239.
5
Neuronal network disintegration: common pathways linking neurodegenerative diseases.神经网络解体:连接神经退行性疾病的共同途径
J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1234-1241. doi: 10.1136/jnnp-2014-308350. Epub 2016 May 12.
6
Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.进行性核上性麻痹中的小脑性共济失调:PSP-C的尸检研究
Mov Disord. 2016 May;31(5):653-62. doi: 10.1002/mds.26499. Epub 2016 Feb 3.
一种与皮质基底节变性相关的疾病特异性代谢脑网络。
Brain. 2014 Nov;137(Pt 11):3036-46. doi: 10.1093/brain/awu256. Epub 2014 Sep 9.
4
The evolution of primary progressive apraxia of speech.原发性进行性言语失用症的演变
Brain. 2014 Oct;137(Pt 10):2783-95. doi: 10.1093/brain/awu223. Epub 2014 Aug 11.
5
Characterization of tau oligomeric seeds in progressive supranuclear palsy.在进行性核上性麻痹中 tau 寡聚体种子的特征。
Acta Neuropathol Commun. 2014 Jun 14;2:73. doi: 10.1186/2051-5960-2-73.
6
Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.两种常见tau蛋白病(阿尔茨海默病和进行性核上性麻痹)中脑脊液tau蛋白的不同改变
J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):244-50. doi: 10.1136/jnnp-2014-308004. Epub 2014 Jun 4.
7
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.达文那肽治疗进行性核上性麻痹患者的随机、双盲、安慰剂对照 2/3 期临床试验。
Lancet Neurol. 2014 Jul;13(7):676-85. doi: 10.1016/S1474-4422(14)70088-2. Epub 2014 May 27.
8
Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes.进行性核上性麻痹与皮质基底节综合征的弥散张量成像比较。
Parkinsonism Relat Disord. 2014 May;20(5):493-8. doi: 10.1016/j.parkreldis.2014.01.023. Epub 2014 Feb 8.
9
Rate of decline in progressive supranuclear palsy.进行性核上性麻痹的衰退率。
Mov Disord. 2014 Apr;29(4):463-8. doi: 10.1002/mds.25843. Epub 2014 Feb 24.
10
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy.GSK-3抑制剂替格列净治疗进行性核上性麻痹的2期试验。
Mov Disord. 2014 Apr;29(4):470-8. doi: 10.1002/mds.25824. Epub 2014 Feb 14.